<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><journal-meta><?QA-only?><journal-title-group><journal-title>Neurolog&#x000ed;a (English Edition)</journal-title></journal-title-group><issn pub-type="ppub">2173-5808</issn><issn pub-type="epub">2173-5808</issn><publisher><publisher-name>Sociedad Espa&#x000f1;ola de Neurolog&#x000ed;a. Published by Elsevier Espa&#x000f1;a, S.L.U.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7164915</article-id><article-id pub-id-type="publisher-id">S2173-5808(20)30052-3</article-id><article-id pub-id-type="doi">10.1016/j.nrleng.2020.03.002</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Should we expect neurological symptoms in the SARS-CoV-2 epidemic?<sup><xref ref-type="fn" rid="d32e719">&#x02606;</xref></sup></article-title><trans-title-group xml:lang="es"><trans-title>&#x000bf;Es esperable que haya cuadros neurol&#x000f3;gicos por la pandemia por SARS-CoV-2?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Mat&#x000ed;as-Guiu</surname><given-names>J.</given-names></name><email>neurol.hcsc@salud.madrid.org</email><xref rid="cor0005" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>Gomez-Pinedo</surname><given-names>U.</given-names></name></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Montero-Escribano</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Gomez-Iglesias</surname><given-names>P.</given-names></name></contrib><contrib contrib-type="author" id="aut0025"><name><surname>Porta-Etessam</surname><given-names>J.</given-names></name></contrib><contrib contrib-type="author" id="aut0030"><name><surname>Matias-Guiu</surname><given-names>J.A.</given-names></name></contrib><aff id="aff0005">Servicio de Neurolog&#x000ed;a, Instituto de Neurociencias, Hospital Cl&#x000ed;nico San Carlos, San Carlos, IdISSC, Madrid, Spain</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding author. <email>neurol.hcsc@salud.madrid.org</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>17</day><month>4</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><month>4</month><year>2020</year></pub-date><pub-date pub-type="epub"><day>17</day><month>4</month><year>2020</year></pub-date><volume>35</volume><issue>3</issue><fpage>170</fpage><lpage>175</lpage><history><date date-type="received"><day>27</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>31</day><month>3</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Sociedad Espa&#x000f1;ola de Neurolog&#x000ed;a. Published by Elsevier Espa&#x000f1;a, S.L.U.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Sociedad Espa&#x000f1;ola de Neurolog&#x000ed;a</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="abs0010"><sec><title>Introduction</title><p>There is growing evidence that SARS-CoV-2 can gain access to the central nervous system (CNS). We revise the literature on coronavirus infection of the CNS associated with neurological diseases.</p></sec><sec><title>Development</title><p>Neurological symptoms were rarely reported in the SARS-CoV and MERS-CoV epidemics, although isolated cases were described. There are also reports of cases of neurological symptoms associated with CoV-OC43 and CoV-229E infection. The presence of neurological lesions, especially demyelinating lesions in the mouse hepatitis virus model, may explain the mechanisms by which coronaviruses enter the CNS, particularly those related with the immune response. This may explain the presence of coronavirus in patients with multiple sclerosis. We review the specific characteristics of SARS-CoV-2 and address the question of whether the high number of cases may be associated with greater CNS involvement.</p></sec><sec><title>Conclusion</title><p>Although neurological symptoms are not frequent in coronavirus epidemics, the high number of patients with SARS-CoV-2 infection may explain the presence of the virus in the CNS and increase the likelihood of early- or delayed-onset neurological symptoms. Follow-up of patients affected by the SARS-CoV-2 epidemic should include careful assessment of the CNS.</p></sec></abstract><trans-abstract xml:lang="es"><title>Resumen</title><sec><title>Introducci&#x000f3;n</title><p>Diversas evidencias sugieren que el SARS-CoV-2 puede penetrar en el sistema nervioso central (SNC). Los autores revisan los datos de la literatura sobre los hallazgos de coronavirus en el SNC asociado a enfermedades neurol&#x000f3;gicas.</p></sec><sec><title>Desarrollo</title><p>En las distintas epidemias con SARS-CoV y MERS-CoV la presencia de cuadros neurol&#x000f3;gicos es baja, pero se describen cuadros aislados de pacientes. Tambi&#x000e9;n existen casos asociados a OC43-CoV y 229E-CoV. La existencia de lesiones neurol&#x000f3;gicas, especialmente desmielinizantes en el modelo MHV-CoV pueden explicar mecanismos de penetraci&#x000f3;n de los CoV en el SNC y especialmente aquellos relacionados con la respuesta inmune, que puede justificar la existencia de CoV en pacientes con esclerosis m&#x000fa;ltiple. Los autores revisan aspectos diferenciales de SARS-CoV-2 y se plantean si debido al alto n&#x000fa;mero de infectados, el virus puede afectar de forma mayor al SNC.</p></sec><sec><title>Conclusi&#x000f3;n</title><p>Aunque la presencia de s&#x000ed;ntomas neurol&#x000f3;gicos en las epidemias de CoV es baja, la mayor frecuencia de infectados por SARS-CoV-2 podr&#x000ed;a justificar el paso del virus y la posibilidad de cl&#x000ed;nica neurol&#x000f3;gica precoz o tard&#x000ed;a con mayor incidencia. El seguimiento de los pacientes de la epidemia debe atender con cuidado a la evaluaci&#x000f3;n del SNC.</p></sec></trans-abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>Coronavirus</kwd><kwd>SARS-CoV</kwd><kwd>MERS-CoV</kwd><kwd>Multiple sclerosis</kwd><kwd>SARS-CoV-2</kwd><kwd>Mouse hepatitis virus</kwd><kwd>Neurological symptoms</kwd><kwd>Central nervous system</kwd></kwd-group><kwd-group xml:lang="es" id="kwd0010"><title>Palabras clave</title><kwd>Coronavirus</kwd><kwd>SARS-CoV</kwd><kwd>MERS-CoV</kwd><kwd>Esclerosis m&#x000fa;ltiple</kwd><kwd>SARS-CoV-2</kwd><kwd>Virus murino de la hepatitis</kwd><kwd>S&#x000ed;ntomas neurol&#x000f3;gicos</kwd><kwd>Sistema nervioso central</kwd></kwd-group></article-meta></front><body><p id="par0005">Human coronavirus (CoV) infection is associated with mild upper and lower respiratory tract symptoms, both in children and in adults. The 4 endemic human coronaviruses HCoV-229E, HCoV-NL63, HCoV-OC43, and HCoV-HKU1 are included among the known causes of common cold. HCoV-229E and HCoV-NL63 are classified as &#x003b1;CoV, whereas HCoV-OC43 and HCoV-HKU1 are &#x003b2;CoV.<xref rid="bib0445" ref-type="bibr"><sup>1</sup></xref> Two new &#x003b2;CoV, SARS-CoV and MERS-CoV, were recently discovered; these present a much more aggressive behaviour and have caused epidemics associated with extrapulmonary manifestations and high mortality rates. In 2003, SARS-CoV was identified as the cause of a severe respiratory syndrome first appearing in the Chinese province of Guangdong; in 2004, MERS-CoV caused an epidemic that mainly affected the Arabian Peninsula. On 31 December 2019, the World Health Organization reported a novel CoV (SARS-CoV-2) in patients with pneumonia in the city of Wuhan, in the Chinese province of Hubei; it subsequently spread rapidly through China and the rest of the world. The novel virus is classified as a &#x003b2;CoV and bears considerable similarity to SARS-CoV. SARS-CoV-2 infection has been declared a pandemic; it is associated with high mortality and has caused significant societal impact. The virus is expected to infect a large proportion of the world's population.</p><p id="par0010">The central nervous system (CNS) is vulnerable to infection: many viruses can reach the brain, including herpesviruses,<xref rid="bib0450" ref-type="bibr"><sup>2</sup></xref> arboviruses,<xref rid="bib0455" ref-type="bibr"><sup>3</sup></xref> measles virus,<xref rid="bib0460" ref-type="bibr"><sup>4</sup></xref> influenza virus, and HIV.<xref rid="bib0450" ref-type="bibr"><sup>2</sup></xref> Coronaviruses may also infect the CNS,<xref rid="bib0465" ref-type="bibr">5</xref>, <xref rid="bib0470" ref-type="bibr">6</xref> which could lead to a high incidence of neurological symptoms. This article reviews the available evidence on the effects of human coronaviruses on the CNS.</p><sec id="sec0005"><title>Neurological symptoms of coronavirus infection</title><p id="par0015">It is an undisputed fact that coronaviruses can infect the CNS. CoV RNA has been detected in the CNS of patients with numerous neurological diseases.<xref rid="bib0475" ref-type="bibr">7</xref>, <xref rid="bib0480" ref-type="bibr">8</xref> CNS infection has caused symptoms of encephalitis in children.<xref rid="bib0485" ref-type="bibr"><sup>9</sup></xref> Cases of meningitis, Guillain-Barr&#x000e9; syndrome, and other neuroimmune disorders have also been reported in the context of CoV infection.<xref rid="bib0490" ref-type="bibr">10</xref>, <xref rid="bib0495" ref-type="bibr">11</xref>, <xref rid="bib0500" ref-type="bibr">12</xref>, <xref rid="bib0505" ref-type="bibr">13</xref>, <xref rid="bib0510" ref-type="bibr">14</xref>, <xref rid="bib0515" ref-type="bibr">15</xref>, <xref rid="bib0520" ref-type="bibr">16</xref> HCoV-OC43 is considered the coronavirus with the greatest neuroinvasive potential, as it has been shown to invade, replicate, and remain in the mouse CNS, causing direct damage to neurons.<xref rid="bib0525" ref-type="bibr">17</xref>, <xref rid="bib0530" ref-type="bibr">18</xref> The virus has also been found to exploit axonal transport.<xref rid="bib0535" ref-type="bibr"><sup>19</sup></xref> HCoV-OC43 can induce cell degeneration and death.<xref rid="bib0540" ref-type="bibr">20</xref>, <xref rid="bib0545" ref-type="bibr">21</xref>, <xref rid="bib0550" ref-type="bibr">22</xref> In humans, HCoV-OC43 has been detected in brain tissue from patients with a wide range of neurological diseases, including Alzheimer disease, Parkinson's disease, and multiple sclerosis, as well as in the brains of healthy individuals. Likewise, HCoV-229E has been associated with febrile seizures.<xref rid="bib0555" ref-type="bibr"><sup>23</sup></xref> The literature also includes a report of an immunocompromised child who died due to HCoV-OC43&#x02013;associated encephalitis.<xref rid="bib0560" ref-type="bibr"><sup>24</sup></xref> Both HCoV-OC43 and HCoV-229E can infect innate immune cells.<xref rid="bib0565" ref-type="bibr">25</xref>, <xref rid="bib0570" ref-type="bibr">26</xref>
</p></sec><sec id="sec0010"><title>MERS-CoV and SARS-CoV</title><p id="par0020">MERS-CoV and SARS-CoV can cause severe lower respiratory tract infections, characterised by acute breathing difficulties and such extrapulmonary manifestations as diarrhoea, lymphocytopaenia, hepatic and renal dysfunction, and multiple organ dysfunction syndrome, both in immunocompetent and immunocompromised individuals. The associated mortality rate is higher than 10%, although some cases are asymptomatic.<xref rid="bib0575" ref-type="bibr"><sup>27</sup></xref> MERS-CoV and SARS-CoV have caused 2 epidemics, with a large number of people infected. Presence of neurological symptoms in these epidemics was rare according to the literature, although the available studies only analyse the initial phase of each epidemic. A retrospective study conducted in Saudi Arabia reported confusion in 25.7% of patients with Middle East respiratory syndrome (MERS), and seizures in 8.6%.<xref rid="bib0580" ref-type="bibr"><sup>28</sup></xref> Only 4 cases of CNS involvement (acute disseminated encephalomyelitis, stroke, and encephalitis) and one case of critical illness polyneuropathy have been reported in the context of MERS.<xref rid="bib0585" ref-type="bibr">29</xref>, <xref rid="bib0590" ref-type="bibr">30</xref> Cases of Guillain-Barr&#x000e9; syndrome and delayed-onset peripheral neuropathy have also been reported, and one article even presents the timeline of neurological symptoms in a patient with MERS.<xref rid="bib0595" ref-type="bibr"><sup>31</sup></xref> The literature also includes a case of MERS-CoV infection associated with intracerebral haemorrhage; according to the author, MERS-CoV infection was the only possible explanation for the stroke, with no other risk factors recorded.<xref rid="bib0600" ref-type="bibr"><sup>32</sup></xref> An in vitro study has shown that certain cell lines, such as human neuronal cell lines, are particularly susceptible to MERS-CoV.<xref rid="bib0605" ref-type="bibr"><sup>33</sup></xref> The delayed onset of neurological complications of MERS-CoV infection, the absence of the virus in cerebrospinal fluid, and the unclear association between MERS-CoV infection and Guillain-Barr&#x000e9; syndrome suggest that the manifestations of MERS-CoV infection involve an immune component.<xref rid="bib0610" ref-type="bibr"><sup>34</sup></xref> According to some authors, however, the failure to detect the virus in biological samples may be explained by methodological issues.<xref rid="bib0615" ref-type="bibr"><sup>35</sup></xref> During the SARS-CoV outbreak of 2002&#x02013;2003, reports of neurological symptoms were anecdotal.<xref rid="bib0620" ref-type="bibr">36</xref>, <xref rid="bib0625" ref-type="bibr">37</xref> Some patients developed axonal polyneuropathy a month after the onset of severe acute respiratory syndrome (SARS), and improved during follow-up. Other patients presented such neuromuscular disorders as myopathy and rhabdomyolysis.<xref rid="bib0630" ref-type="bibr">38</xref>, <xref rid="bib0635" ref-type="bibr">39</xref> SARS is associated with more severe symptoms than non-SARS viral respiratory tract infection.<xref rid="bib0640" ref-type="bibr"><sup>40</sup></xref> Therefore, muscular disorders may be the result of the patients&#x02019; critical situation rather than the virus itself. Stroke has also been reported in the context of SARS-CoV infection.<xref rid="bib0645" ref-type="bibr">41</xref>, <xref rid="bib0650" ref-type="bibr">42</xref>
</p></sec><sec id="sec0015"><title>Coronaviruses and multiple sclerosis</title><p id="par0025">CoV infection has been proposed as a contributing factor in the pathogenesis of multiple sclerosis (MS).<xref rid="bib0655" ref-type="bibr"><sup>43</sup></xref> This hypothesis is supported by findings from several studies. Coronavirus-like particles have been detected in autopsied brain tissue from a patient with MS.<xref rid="bib0660" ref-type="bibr"><sup>44</sup></xref> CoV isolates were identified in autopsied brain tissue from 2 patients with MS,<xref rid="bib0665" ref-type="bibr"><sup>45</sup></xref> and other researchers have detected CoV RNA in brain tissue from patients with MS.<xref rid="bib0670" ref-type="bibr">46</xref>, <xref rid="bib0675" ref-type="bibr">47</xref>, <xref rid="bib0680" ref-type="bibr">48</xref> Another study reports intrathecal synthesis of antibodies to human CoV, which suggests CNS infection.<xref rid="bib0685" ref-type="bibr"><sup>49</sup></xref> Human CoV RNA has also been detected in the cerebrospinal fluid of patients with MS.<xref rid="bib0690" ref-type="bibr"><sup>50</sup></xref> Experimental studies have found that human CoV can infect neurons, astrocytes, and microglia in primary cultures,<xref rid="bib0695" ref-type="bibr"><sup>51</sup></xref> as well as immortalised human microglial cells.<xref rid="bib0700" ref-type="bibr"><sup>52</sup></xref> Interestingly, human CoV can also infect oligodendrocytic cell lines.<xref rid="bib0705" ref-type="bibr"><sup>53</sup></xref> The hypothesis is further supported by the fact that viral upper respiratory tract infections, which may be associated with human coronaviruses, constitute an important trigger of MS relapses.<xref rid="bib0710" ref-type="bibr">54</xref>, <xref rid="bib0715" ref-type="bibr">55</xref>
</p></sec><sec id="sec0020"><title>Mouse hepatitis virus</title><p id="par0030">Mouse hepatitis virus (MHV) is a coronavirus that infects mice but not humans.<xref rid="bib0720" ref-type="bibr"><sup>56</sup></xref> As it induces neurological disorders,<xref rid="bib0725" ref-type="bibr">57</xref>, <xref rid="bib0730" ref-type="bibr">58</xref> it constitutes an excellent experimental model for studying the effects of coronaviruses on the CNS. Neurotropic MHV strains can infect the CNS by intranasal or intravenous inoculation both in mice<xref rid="bib0735" ref-type="bibr"><sup>59</sup></xref> and in primates.<xref rid="bib0740" ref-type="bibr"><sup>60</sup></xref> Viral entry through the blood-brain barrier has been associated with downregulation of interferon beta production in brain microvascular endothelial cells.<xref rid="bib0745" ref-type="bibr"><sup>61</sup></xref> MHV infection causes acute encephalomyelitis associated with focal areas of demyelination; the role of the immune response during viral infection has been studied.<xref rid="bib0750" ref-type="bibr"><sup>62</sup></xref> Microglial activation and inflammatory mediator expression in the CNS contribute to a local microenvironment that regulates viral replication, which may promote demyelination.<xref rid="bib0755" ref-type="bibr"><sup>63</sup></xref> The demyelinating lesions associated with MHV infection suggest that this model may be useful in multiple sclerosis research.</p></sec><sec id="sec0025"><title>The SARS-CoV-2 epidemic and the hypothesis of the brain as a viral reservoir</title><p id="par0035">Although SARS-CoV and SARS-CoV-2 are similar in many respects, they present genetic and structural differences.<xref rid="bib0760" ref-type="bibr"><sup>64</sup></xref> The novel virus is characterised by the ease with which it spreads<xref rid="bib0765" ref-type="bibr"><sup>65</sup></xref>; it is more contagious than SARS-CoV,<xref rid="bib0770" ref-type="bibr"><sup>66</sup></xref> spreading through respiratory droplets and contact with infected individuals and objects. It can also be spread by asymptomatic infected individuals.<xref rid="bib0775" ref-type="bibr">67</xref>, <xref rid="bib0780" ref-type="bibr">68</xref>, <xref rid="bib0785" ref-type="bibr">69</xref> Several observational studies have analysed the symptoms of the disease, but few have addressed neurological symptoms, with the exception of headache and vestibular symptoms in observational studies<xref rid="bib0790" ref-type="bibr">70</xref>, <xref rid="bib0795" ref-type="bibr">71</xref>, <xref rid="bib0800" ref-type="bibr">72</xref>, <xref rid="bib0805" ref-type="bibr">73</xref>, <xref rid="bib0810" ref-type="bibr">74</xref>, <xref rid="bib0815" ref-type="bibr">75</xref> and a specific study of these symptoms in hospitalised patients,<xref rid="bib0820" ref-type="bibr"><sup>76</sup></xref> and isolated case reports<xref rid="bib0825" ref-type="bibr"><sup>77</sup></xref>. However, it has been suggested that the virus may affect the CNS, similarly to SARS-CoV, which was detected in the brains of some patients.<xref rid="bib0830" ref-type="bibr"><sup>78</sup></xref> Clinical data reveal differential characteristics, including olfactory alterations and hallucinations; these symptoms have not been reported in patients with SARS-CoV or MERS-CoV infection. Several features of SARS-CoV-2 support the hypothesis of a particular affinity for the CNS.</p><p id="par0040">The main structural differences between SARS-CoV and SARS-CoV-2 are observed in the fusion protein and in accessory proteins ORF3b and ORF8. The coronavirus genome encodes 4 main structural proteins, namely spike, envelope, membrane, and nucleocapsid proteins.<xref rid="bib0835" ref-type="bibr"><sup>79</sup></xref> The viral surface glycoprotein (S) may induce neurodegeneration.<xref rid="bib0840" ref-type="bibr"><sup>80</sup></xref> After infecting host cells, the viral genome is translated into 2 large precursor polyproteins, which are processed by ORF1a-encoded viral proteinases into 16 mature nonstructural proteins (nsp1-nsp16). Nonstructural proteins play an essential role in viral RNA replication and transcription,<xref rid="bib0845" ref-type="bibr"><sup>81</sup></xref> whereas ORF3b has been associated with the immune response.<xref rid="bib0850" ref-type="bibr"><sup>82</sup></xref> As occurs with SARS-CoV, the SARS-CoV-2 spike glycoprotein S1 subunit receptor-binding domain binds to ACE2 receptors, the site of viral entry into the host cell; this has given rise to the possibility of creating an experimental model of SARS-CoV-2 infection.<xref rid="bib0855" ref-type="bibr"><sup>83</sup></xref> Interestingly, the ACE2 receptor is widely expressed in the brain,<xref rid="bib0860" ref-type="bibr"><sup>84</sup></xref> which supports the hypothesis that CNS involvement may be common in the SARS-CoV-2 epidemic.<xref rid="bib0865" ref-type="bibr"><sup>85</sup></xref> In vitro studies report a positive correlation between ACE2 expression and SARS-CoV infection.<xref rid="bib0870" ref-type="bibr"><sup>86</sup></xref> Viruses can enter the CNS via the haematogenous route (in which the virus infects the endothelial cells of the blood-brain barrier) or the neuronal route. It is unlikely that SARS-CoV-2 is able to cross the blood-brain barrier<xref rid="bib0875" ref-type="bibr"><sup>87</sup></xref> due to its large size; the most likely entry route is through the olfactory or trigeminal nerves. Thus, the high incidence of olfactory alterations in SARS-CoV-2&#x02013;infected individuals may indicate viral entry into the CNS. Findings from studies of the MHV model and the detection of CoV in patients&#x02019; brains suggest that the virus may remain in the host's CNS for long periods of time without causing neurological symptoms and that the brain may be a viral reservoir.<xref rid="bib0880" ref-type="bibr"><sup>88</sup></xref>
</p></sec><sec id="sec0030"><title>Conclusions</title><p id="par0045">Coronaviruses can enter the CNS, where they may either damage CNS cells or remain latent. Although neurological symptoms are not frequent, they may indicate viral entry into the CNS, which may cause early- or delayed-onset neurological symptoms. Follow-up of patients with SARS-CoV-2 infection should include careful assessment of the CNS.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0445"><label>1</label><element-citation publication-type="journal" id="sbref0445"><person-group person-group-type="author"><name><surname>Corman</surname><given-names>V.M.</given-names></name><name><surname>Muth</surname><given-names>D.</given-names></name><name><surname>Niemeyer</surname><given-names>D.</given-names></name><name><surname>Drosten</surname><given-names>C.</given-names></name></person-group><article-title>Hosts and sources of endemic human coronaviruses</article-title><source>Adv Virus Res</source><volume>100</volume><year>2018</year><fpage>163</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/bs.aivir.2018.01.001</pub-id><pub-id pub-id-type="pmid">29551135</pub-id></element-citation></ref><ref id="bib0450"><label>2</label><element-citation publication-type="journal" id="sbref0450"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Ikezu</surname><given-names>T.</given-names></name></person-group><article-title>The comorbidity of HIV-associated neurocognitive disorders and Alzheimer's disease: a foreseeable medical challenge in post-HAART era</article-title><source>J Neuroimmune Pharmacol</source><volume>4</volume><year>2009</year><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1007/s11481-008-9136-0</pub-id><pub-id pub-id-type="pmid">19016329</pub-id></element-citation></ref><ref id="bib0455"><label>3</label><element-citation publication-type="journal" id="sbref0455"><person-group person-group-type="author"><name><surname>Brask</surname><given-names>J.</given-names></name><name><surname>Chauhan</surname><given-names>A.</given-names></name><name><surname>Hill</surname><given-names>R.H.</given-names></name><name><surname>Ljunggren</surname><given-names>H.G.</given-names></name><name><surname>Kristensson</surname><given-names>K.</given-names></name></person-group><article-title>Effects on synaptic activity in cultured hippocampal neurons by influenza A viral proteins</article-title><source>J Neurovirol</source><volume>11</volume><year>2005</year><fpage>395</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1080/13550280500186916</pub-id><pub-id pub-id-type="pmid">16162482</pub-id></element-citation></ref><ref id="bib0460"><label>4</label><element-citation publication-type="journal" id="sbref0460"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>Y.</given-names></name><name><surname>Hotta</surname><given-names>H.</given-names></name><name><surname>Nishimura</surname><given-names>A.</given-names></name><name><surname>Tatsuno</surname><given-names>Y.</given-names></name><name><surname>Homma</surname><given-names>M.</given-names></name></person-group><article-title>Detection of measles virus nucleoprotein mRNA in autopsied brain tissues</article-title><source>J Gen Virol</source><volume>76</volume><year>1995</year><fpage>3201</fpage><lpage>3204</lpage><pub-id pub-id-type="pmid">8847530</pub-id></element-citation></ref><ref id="bib0465"><label>5</label><element-citation publication-type="journal" id="sbref0465"><person-group person-group-type="author"><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>le Coupanec</surname><given-names>A.</given-names></name><name><surname>Stodola</surname><given-names>J.K.</given-names></name><name><surname>Meessen-Pinard</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Human coronaviruses: viral and cellular factors involved in neuroinvasiveness and neuropathogenesis</article-title><source>Virus Res</source><volume>194</volume><year>2014</year><fpage>145</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">25281913</pub-id></element-citation></ref><ref id="bib0470"><label>6</label><element-citation publication-type="journal" id="sbref0470"><person-group person-group-type="author"><name><surname>Bohmwald</surname><given-names>K.</given-names></name><name><surname>G&#x000e1;lvez</surname><given-names>N.M.S.</given-names></name><name><surname>R&#x000ed;os</surname><given-names>M.</given-names></name><name><surname>Kalergis</surname><given-names>A.M.</given-names></name></person-group><article-title>Neurologic alterations due to respiratory virus infections</article-title><source>Front Cell Neurosci</source><volume>12</volume><year>2018</year><fpage>386</fpage><pub-id pub-id-type="doi">10.3389/fncel.2018.00386</pub-id><pub-id pub-id-type="pmid">30416428</pub-id></element-citation></ref><ref id="bib0475"><label>7</label><element-citation publication-type="journal" id="sbref0475"><person-group person-group-type="author"><name><surname>Arbour</surname><given-names>N.</given-names></name><name><surname>Day</surname><given-names>R.</given-names></name><name><surname>Newcombe</surname><given-names>J.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Neuroinvasion by human respiratory coronaviruses</article-title><source>J Virol</source><volume>74</volume><year>2000</year><fpage>8913</fpage><lpage>8921</lpage><pub-id pub-id-type="pmid">10982334</pub-id></element-citation></ref><ref id="bib0480"><label>8</label><element-citation publication-type="journal" id="sbref0480"><person-group person-group-type="author"><name><surname>Fazzini</surname><given-names>E.</given-names></name><name><surname>Fleming</surname><given-names>J.</given-names></name><name><surname>Fahn</surname><given-names>S.</given-names></name></person-group><article-title>Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease</article-title><source>Mov Disord</source><volume>7</volume><year>1992</year><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">1316552</pub-id></element-citation></ref><ref id="bib0485"><label>9</label><element-citation publication-type="journal" id="sbref0485"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>R.</given-names></name><name><surname>Wen</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Cao</surname><given-names>X.</given-names></name></person-group><article-title>Coronavirus infections in the central nervous system and respiratory tract show distinct features in hospitalized children</article-title><source>Intervirology</source><volume>59</volume><year>2016</year><fpage>163</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1159/000453066</pub-id><pub-id pub-id-type="pmid">28103598</pub-id></element-citation></ref><ref id="bib0490"><label>10</label><element-citation publication-type="journal" id="sbref0490"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>E.A.</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name><name><surname>Cohen</surname><given-names>M.E.</given-names></name><name><surname>Duffner</surname><given-names>P.K.</given-names></name><name><surname>Faden</surname><given-names>H.</given-names></name></person-group><article-title>Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis</article-title><source>Pediatrics</source><volume>113</volume><year>2004</year><fpage>e73</fpage><lpage>e76</lpage><pub-id pub-id-type="pmid">14702500</pub-id></element-citation></ref><ref id="bib0495"><label>11</label><element-citation publication-type="journal" id="sbref0495"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>K.K.</given-names></name><name><surname>Yu</surname><given-names>W.C.</given-names></name><name><surname>Chu</surname><given-names>C.M.</given-names></name><name><surname>Lau</surname><given-names>S.T.</given-names></name><name><surname>Sheng</surname><given-names>B.</given-names></name><name><surname>Yuen</surname><given-names>K.Y.</given-names></name></person-group><article-title>Possible central nervous system infection by SARS coronavirus</article-title><source>Emerg Infect Dis</source><volume>10</volume><year>2004</year><fpage>342</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.3201/eid1002.030638</pub-id><pub-id pub-id-type="pmid">15030709</pub-id></element-citation></ref><ref id="bib0500"><label>12</label><element-citation publication-type="journal" id="sbref0500"><person-group person-group-type="author"><name><surname>Turgay</surname><given-names>C.</given-names></name><name><surname>Emine</surname><given-names>T.</given-names></name><name><surname>Ozlem</surname><given-names>K.</given-names></name><name><surname>Muhammet</surname><given-names>S.P.</given-names></name><name><surname>Haydar</surname><given-names>A.T.</given-names></name></person-group><article-title>A rare cause of acute flaccid paralysis: human coronaviruses</article-title><source>J Pediatr Neurosci</source><volume>10</volume><year>2015</year><fpage>280</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.4103/1817-1745.165716</pub-id><pub-id pub-id-type="pmid">26557177</pub-id></element-citation></ref><ref id="bib0505"><label>13</label><element-citation publication-type="journal" id="sbref0505"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Tengsupakul</surname><given-names>S.</given-names></name><name><surname>Sanchez</surname><given-names>O.</given-names></name><name><surname>Phaltas</surname><given-names>R.</given-names></name><name><surname>Maertens</surname><given-names>P.</given-names></name></person-group><article-title>Guillain-Barre syndrome with unilateral peripheral facial and bulbar palsy in a child: a case report</article-title><source>SAGE Open Med Case Rep</source><volume>7</volume><year>2019</year><pub-id pub-id-type="doi">10.1177/2050313X19838750</pub-id></element-citation></ref><ref id="bib0510"><label>14</label><element-citation publication-type="journal" id="sbref0510"><person-group person-group-type="author"><name><surname>Algahtani</surname><given-names>H.</given-names></name><name><surname>Subahi</surname><given-names>A.</given-names></name><name><surname>Shirah</surname><given-names>B.</given-names></name></person-group><article-title>Neurological complications of middle east respiratory syndrome coronavirus: a report of two cases and review of the literature</article-title><source>Case Rep Neurol Med</source><volume>2016</volume><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/3502683</pub-id><comment>3502683</comment></element-citation></ref><ref id="bib0515"><label>15</label><element-citation publication-type="journal" id="sbref0515"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>E.A.</given-names></name><name><surname>Collins</surname><given-names>A.</given-names></name><name><surname>Cohen</surname><given-names>M.E.</given-names></name><name><surname>Duffner</surname><given-names>P.K.</given-names></name><name><surname>Faden</surname><given-names>H.</given-names></name></person-group><article-title>Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis</article-title><source>Pediatrics</source><volume>113</volume><year>2004</year><fpage>e73</fpage><lpage>e76</lpage><pub-id pub-id-type="doi">10.1542/peds.113.1.e73</pub-id><pub-id pub-id-type="pmid">14702500</pub-id></element-citation></ref><ref id="bib0520"><label>16</label><element-citation publication-type="journal" id="sbref0520"><person-group person-group-type="author"><name><surname>McGavern</surname><given-names>D.B.</given-names></name><name><surname>Kang</surname><given-names>S.S.</given-names></name></person-group><article-title>Illuminating viral infections in the nervous system</article-title><source>Nat Rev Immunol</source><volume>11</volume><year>2011</year><fpage>318</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1038/nri2971</pub-id><pub-id pub-id-type="pmid">21508982</pub-id></element-citation></ref><ref id="bib0525"><label>17</label><element-citation publication-type="journal" id="sbref0525"><person-group person-group-type="author"><name><surname>Jacomy</surname><given-names>H.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Vacuolating encephalitis in mice infected by human coronavirus OC43</article-title><source>Virology</source><volume>315</volume><year>2003</year><fpage>20</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/S0042-6822(03)00323-4</pub-id><pub-id pub-id-type="pmid">14592756</pub-id></element-citation></ref><ref id="bib0530"><label>18</label><element-citation publication-type="journal" id="sbref0530"><person-group person-group-type="author"><name><surname>Jacomy</surname><given-names>H.</given-names></name><name><surname>Fragoso</surname><given-names>G.</given-names></name><name><surname>Almazan</surname><given-names>G.</given-names></name><name><surname>Mushynski</surname><given-names>W.E.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice</article-title><source>Virology</source><volume>349</volume><year>2006</year><fpage>335</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2006.01.049</pub-id><pub-id pub-id-type="pmid">16527322</pub-id></element-citation></ref><ref id="bib0535"><label>19</label><element-citation publication-type="journal" id="sbref0535"><person-group person-group-type="author"><name><surname>Dub&#x000e9;</surname><given-names>M.</given-names></name><name><surname>le Coupanec</surname><given-names>A.</given-names></name><name><surname>Wong</surname><given-names>A.H.M.</given-names></name><name><surname>Rini</surname><given-names>J.M.</given-names></name><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Axonal transport enables neuron-to-neuron propagation of human coronavirus OC43</article-title><source>J Virol</source><volume>92</volume><year>2018</year><fpage>e00404</fpage><lpage>e418</lpage><pub-id pub-id-type="other">10.1128/JVI. 00404-18</pub-id><pub-id pub-id-type="pmid">29925652</pub-id></element-citation></ref><ref id="bib0540"><label>20</label><element-citation publication-type="journal" id="sbref0540"><person-group person-group-type="author"><name><surname>Favreau</surname><given-names>D.J.</given-names></name><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>St-Jean</surname><given-names>J.R.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>A human coronavirus OC43 variant harboring persistence-associated mutations in the S glycoprotein differentially induces the unfolded protein response in human neurons as compared to wild-type virus</article-title><source>Virology</source><volume>395</volume><year>2009</year><fpage>255</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2009.09.026</pub-id><pub-id pub-id-type="pmid">19846189</pub-id></element-citation></ref><ref id="bib0545"><label>21</label><element-citation publication-type="journal" id="sbref0545"><person-group person-group-type="author"><name><surname>Favreau</surname><given-names>D.J.</given-names></name><name><surname>Meessen-Pinard</surname><given-names>M.</given-names></name><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Human coronavirus-induced neuronal programmed cell death is cyclophilin D dependent and potentially caspase dispensable</article-title><source>J Virol</source><volume>86</volume><year>2012</year><fpage>81</fpage><lpage>93</lpage><pub-id pub-id-type="other">10.1128/JVI. 06062-11</pub-id><pub-id pub-id-type="pmid">22013052</pub-id></element-citation></ref><ref id="bib0550"><label>22</label><element-citation publication-type="journal" id="sbref0550"><person-group person-group-type="author"><name><surname>Meessen-Pinard</surname><given-names>M.</given-names></name><name><surname>le Coupanec</surname><given-names>A.</given-names></name><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Pivotal role of receptor-interacting protein kinase 1 and mixed lineage kinase domain-like in neuronal cell death induced by the human neuroinvasive coronavirus OC43</article-title><source>J Virol</source><year>2016</year><fpage>91</fpage><pub-id pub-id-type="other">10.1128/JVI. 01513-1</pub-id></element-citation></ref><ref id="bib0555"><label>23</label><element-citation publication-type="journal" id="sbref0555"><person-group person-group-type="author"><name><surname>Harman</surname><given-names>K.B.</given-names></name><name><surname>Calik</surname><given-names>M.</given-names></name><name><surname>Karal</surname><given-names>Y.</given-names></name><name><surname>Isikay</surname><given-names>S.</given-names></name><name><surname>Kocak</surname><given-names>O.</given-names></name><name><surname>Ozcelik</surname><given-names>A.</given-names></name></person-group><article-title>Viral etiological causes of febrile seizures for respiratory pathogens (EFES Study)</article-title><source>Hum Vaccin Immunother</source><volume>15</volume><year>2019</year><fpage>496</fpage><lpage>502</lpage><pub-id pub-id-type="other">10.1080/21645515.2018.1526588. E</pub-id><pub-id pub-id-type="pmid">30235060</pub-id></element-citation></ref><ref id="bib0560"><label>24</label><element-citation publication-type="journal" id="sbref0560"><person-group person-group-type="author"><name><surname>Morfopoulou</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>J.R.</given-names></name><name><surname>Davies</surname><given-names>E.G.</given-names></name><name><surname>Anderson</surname><given-names>G.</given-names></name><name><surname>Virasami</surname><given-names>A.</given-names></name><name><surname>Qasim</surname><given-names>W.</given-names></name></person-group><article-title>Human coronavirus OC43 associated with fatal encephalitis</article-title><source>N Engl J Med</source><volume>375</volume><year>2016</year><fpage>497</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1056/NEJMc1509458</pub-id><pub-id pub-id-type="pmid">27518687</pub-id></element-citation></ref><ref id="bib0565"><label>25</label><element-citation publication-type="journal" id="sbref0565"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>A.R.</given-names></name></person-group><article-title>Human macrophages are susceptible to coronavirus OC43</article-title><source>Adv Exp Med Biol</source><volume>440</volume><year>1998</year><fpage>635</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">9782339</pub-id></element-citation></ref><ref id="bib0570"><label>26</label><element-citation publication-type="journal" id="sbref0570"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>S.</given-names></name><name><surname>Macnaughton</surname><given-names>M.</given-names></name></person-group><article-title>R. Replication of human respiratory coronavirus strain 229E in human macrophages</article-title><source>J Gen Virol</source><volume>60</volume><year>1982</year><fpage>307</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">7108490</pub-id></element-citation></ref><ref id="bib0575"><label>27</label><element-citation publication-type="journal" id="sbref0575"><person-group person-group-type="author"><collab>Who Mers-Cov Research Group</collab></person-group><article-title>State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans</article-title><source>PLoS Curr</source><volume>5</volume><year>2013</year><pub-id pub-id-type="doi">10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8</pub-id></element-citation></ref><ref id="bib0580"><label>28</label><element-citation publication-type="journal" id="sbref0580"><person-group person-group-type="author"><name><surname>Saad</surname><given-names>M.</given-names></name><name><surname>Omrani</surname><given-names>A.S.</given-names></name><name><surname>Baig</surname><given-names>K.</given-names></name><name><surname>Bahloul</surname><given-names>A.</given-names></name><name><surname>Elzein</surname><given-names>F.</given-names></name><name><surname>Matin</surname><given-names>M.A.</given-names></name></person-group><article-title>Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia</article-title><source>Int J Infect Dis</source><volume>29</volume><year>2014</year><fpage>301</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">25303830</pub-id></element-citation></ref><ref id="bib0585"><label>29</label><element-citation publication-type="journal" id="sbref0585"><person-group person-group-type="author"><name><surname>Arabi</surname><given-names>Y.M.</given-names></name><name><surname>Harthi</surname><given-names>A.</given-names></name><name><surname>Hussein</surname><given-names>J.</given-names></name><name><surname>Bouchama</surname><given-names>A.</given-names></name><name><surname>Johani</surname><given-names>S.</given-names></name><name><surname>Hajeer</surname><given-names>A.H.</given-names></name></person-group><article-title>Severe neurologic syndrome associated with Middle East respiratory syndrome corona virus (MERS-CoV)</article-title><source>Infection</source><volume>43</volume><year>2015</year><fpage>495</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">25600929</pub-id></element-citation></ref><ref id="bib0590"><label>30</label><element-citation publication-type="journal" id="sbref0590"><person-group person-group-type="author"><name><surname>Algahtani</surname><given-names>H.</given-names></name><name><surname>Subahi</surname><given-names>A.</given-names></name><name><surname>Shirah</surname><given-names>B.</given-names></name></person-group><article-title>Neurological complications of Middle East respiratory syndrome coronavirus: a report of two cases and review of the literature</article-title><source>Case Rep Neurol Med</source><volume>2016</volume><year>2016</year><comment>3502683</comment></element-citation></ref><ref id="bib0595"><label>31</label><element-citation publication-type="journal" id="sbref0595"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J.E.</given-names></name><name><surname>Heo</surname><given-names>J.H.</given-names></name><name><surname>Kim</surname><given-names>H.O.</given-names></name><name><surname>Song</surname><given-names>S.H.</given-names></name><name><surname>Park</surname><given-names>S.S.</given-names></name><name><surname>Park</surname><given-names>T.H.</given-names></name></person-group><article-title>Neurological complications during treatment of middle east respiratory syndrome</article-title><source>J Clin Neurol</source><volume>13</volume><year>2017</year><fpage>227</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.3988/jcn.2017.13.3.227</pub-id><pub-id pub-id-type="pmid">28748673</pub-id></element-citation></ref><ref id="bib0600"><label>32</label><element-citation publication-type="journal" id="sbref0600"><person-group person-group-type="author"><name><surname>Al-Hameed</surname><given-names>F.M.</given-names></name></person-group><article-title>Spontaneous intracranial hemorrhage in a patient with Middle East respiratory syndrome corona virus</article-title><source>Saudi Med J</source><volume>38</volume><year>2017</year><fpage>196</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.15537/smj.2017.2.16255</pub-id><pub-id pub-id-type="pmid">28133694</pub-id></element-citation></ref><ref id="bib0605"><label>33</label><element-citation publication-type="journal" id="sbref0605"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Chan</surname><given-names>K.H.</given-names></name><name><surname>Choi</surname><given-names>G.K.</given-names></name><name><surname>To</surname><given-names>K.K.</given-names></name><name><surname>Tse</surname><given-names>H.</given-names></name><name><surname>Cai</surname><given-names>J.P.</given-names></name></person-group><article-title>Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation</article-title><source>J Infect Dis</source><volume>207</volume><year>2013</year><fpage>1743</fpage><lpage>1752</lpage><pub-id pub-id-type="pmid">23532101</pub-id></element-citation></ref><ref id="bib0610"><label>34</label><element-citation publication-type="journal" id="sbref0610"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>P.J.</given-names></name><name><surname>Arnold</surname><given-names>D.</given-names></name><name><surname>Antel</surname><given-names>J.P.</given-names></name></person-group><article-title>Virus-induced autoimmune reactions in the CNS</article-title><source>Curr Top Microbiol Immunol</source><volume>253</volume><year>2001</year><fpage>247</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">11417138</pub-id></element-citation></ref><ref id="bib0615"><label>35</label><element-citation publication-type="journal" id="sbref0615"><person-group person-group-type="author"><name><surname>Leland</surname><given-names>D.S.</given-names></name><name><surname>Ginocchio</surname><given-names>C.C.</given-names></name></person-group><article-title>Role of cell culture for virus detection in the age of technology</article-title><source>Clin Microbiol Rev</source><volume>20</volume><year>2007</year><fpage>49</fpage><lpage>78</lpage><pub-id pub-id-type="other">10.1128/CMR. 00002-06</pub-id><pub-id pub-id-type="pmid">17223623</pub-id></element-citation></ref><ref id="bib0620"><label>36</label><element-citation publication-type="journal" id="sbref0620"><person-group person-group-type="author"><name><surname>Stainsby</surname><given-names>B.</given-names></name><name><surname>Howitt</surname><given-names>S.</given-names></name><name><surname>Porr</surname><given-names>J.</given-names></name></person-group><article-title>Neuromusculoskeletal disorders following SARS: a case series</article-title><source>J Can Chiropr Assoc</source><volume>55</volume><year>2011</year><fpage>32</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">21403780</pub-id></element-citation></ref><ref id="bib0625"><label>37</label><element-citation publication-type="journal" id="sbref0625"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>C.C.</given-names></name></person-group><article-title>Peripheral nerve disease in SARS: report of a case</article-title><source>Neurology</source><volume>61</volume><year>2003</year><fpage>1820</fpage><lpage>1821</lpage><pub-id pub-id-type="pmid">14694063</pub-id></element-citation></ref><ref id="bib0630"><label>38</label><element-citation publication-type="journal" id="sbref0630"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>L.K.</given-names></name><name><surname>Hsieh</surname><given-names>S.T.</given-names></name><name><surname>Chao</surname><given-names>C.C.</given-names></name><name><surname>Chen</surname><given-names>Y.C.</given-names></name><name><surname>Lin</surname><given-names>Y.H.</given-names></name><name><surname>Chang</surname><given-names>S.C.</given-names></name></person-group><article-title>Neuromuscular disorders in severe acute respiratory syndrome</article-title><source>Arch Neurol</source><volume>61</volume><year>2004</year><fpage>1669</fpage><lpage>1673</lpage><pub-id pub-id-type="pmid">15534177</pub-id></element-citation></ref><ref id="bib0635"><label>39</label><element-citation publication-type="journal" id="sbref0635"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>T.W.</given-names></name><name><surname>Wong</surname><given-names>K.S.</given-names></name><name><surname>Hui</surname><given-names>A.C.</given-names></name><name><surname>To</surname><given-names>K.F.</given-names></name><name><surname>Lai</surname><given-names>S.T.</given-names></name><name><surname>Ng</surname><given-names>W.F.</given-names></name></person-group><article-title>Myopathic changes associated with severe acute respiratory syndrome</article-title><source>Arch Neurol</source><volume>62</volume><year>2005</year><fpage>1113</fpage><lpage>1117</lpage><pub-id pub-id-type="pmid">16009768</pub-id></element-citation></ref><ref id="bib0640"><label>40</label><element-citation publication-type="journal" id="sbref0640"><person-group person-group-type="author"><name><surname>Rainer</surname><given-names>T.H.</given-names></name><name><surname>Lee</surname><given-names>N.</given-names></name><name><surname>Ip</surname><given-names>M.</given-names></name><name><surname>Galvani</surname><given-names>A.P.</given-names></name><name><surname>Antonio</surname><given-names>G.E.</given-names></name><name><surname>Wong</surname><given-names>K.T.</given-names></name></person-group><article-title>Features discriminating SARS from other severe viral respiratory tract infections</article-title><source>Eur J Clin Microbiol Infect Dis</source><volume>26</volume><year>2007</year><fpage>121</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">17219094</pub-id></element-citation></ref><ref id="bib0645"><label>41</label><element-citation publication-type="journal" id="sbref0645"><person-group person-group-type="author"><name><surname>Umapathi</surname><given-names>T.</given-names></name><name><surname>Kor</surname><given-names>A.C.</given-names></name><name><surname>Venketasubramanian</surname><given-names>N.</given-names></name><name><surname>Lim</surname><given-names>C.C.</given-names></name><name><surname>Pang</surname><given-names>B.C.</given-names></name><name><surname>Yeo</surname><given-names>T.T.</given-names></name></person-group><article-title>Large artery ischaemic stroke in severe acute respiratory syndrome (SARS)</article-title><source>J Neurol</source><volume>251</volume><year>2004</year><fpage>1227</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">15503102</pub-id></element-citation></ref><ref id="bib0650"><label>42</label><element-citation publication-type="journal" id="sbref0650"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>L.K.</given-names></name><name><surname>Hsieh</surname><given-names>S.T.</given-names></name><name><surname>Chang</surname><given-names>Y.C.</given-names></name></person-group><article-title>Neurological manifestations in severe acute respiratory syndrome</article-title><source>Acta Neurol Taiwan</source><volume>14</volume><year>2005</year><fpage>113</fpage><lpage>119</lpage><comment>Abstract</comment><pub-id pub-id-type="pmid">16252612</pub-id></element-citation></ref><ref id="bib0655"><label>43</label><element-citation publication-type="journal" id="sbref0655"><person-group person-group-type="author"><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Virus-induced autoimmunity in multiple sclerosis: the coronavirus paradigm</article-title><source>Adv Clin Neurosci</source><volume>7</volume><year>1997</year><fpage>215</fpage><lpage>233</lpage></element-citation></ref><ref id="bib0660"><label>44</label><element-citation publication-type="journal" id="sbref0660"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>R.</given-names></name><name><surname>Iwasaki</surname><given-names>Y.</given-names></name><name><surname>Koprowski</surname><given-names>H.</given-names></name></person-group><article-title>Intracisternal virus-like particles in brain of a multiple sclerosis patient</article-title><source>J Neurol Sci</source><volume>28</volume><year>1976</year><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">932771</pub-id></element-citation></ref><ref id="bib0665"><label>45</label><element-citation publication-type="journal" id="sbref0665"><person-group person-group-type="author"><name><surname>Burks</surname><given-names>J.S.</given-names></name><name><surname>DeVald</surname><given-names>B.L.</given-names></name><name><surname>Jankovsky</surname><given-names>L.D.</given-names></name><name><surname>Gerdes</surname><given-names>J.</given-names></name></person-group><article-title>C. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients</article-title><source>Science</source><volume>209</volume><year>1980</year><fpage>933</fpage><lpage>934</lpage><pub-id pub-id-type="pmid">7403860</pub-id></element-citation></ref><ref id="bib0670"><label>46</label><element-citation publication-type="journal" id="sbref0670"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>R.S.</given-names></name><name><surname>Brown</surname><given-names>B.</given-names></name><name><surname>Brian</surname><given-names>D.</given-names></name><name><surname>Cabirac</surname><given-names>G.F.</given-names></name></person-group><article-title>Detection of coronavirus RNA and antigen in multiple sclerosis brain</article-title><source>Ann Neurol</source><volume>31</volume><year>1992</year><fpage>525</fpage><lpage>533</lpage><pub-id pub-id-type="pmid">1596089</pub-id></element-citation></ref><ref id="bib0675"><label>47</label><element-citation publication-type="journal" id="sbref0675"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>J.N.</given-names></name><name><surname>Mounir</surname><given-names>S.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Human coronavirus gene expression in the brains of multiple sclerosis patients</article-title><source>Virology</source><volume>191</volume><year>1992</year><fpage>502</fpage><lpage>505</lpage><pub-id pub-id-type="pmid">1413524</pub-id></element-citation></ref><ref id="bib0680"><label>48</label><element-citation publication-type="journal" id="sbref0680"><person-group person-group-type="author"><name><surname>Dessau</surname><given-names>R.B.</given-names></name><name><surname>Lisby</surname><given-names>G.</given-names></name><name><surname>Frederiksen</surname><given-names>J.L.</given-names></name></person-group><article-title>Coronaviruses in brain tissue from patients with multiple sclerosis</article-title><source>Acta Neuropathol</source><volume>101</volume><year>2001</year><fpage>601</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">11515789</pub-id></element-citation></ref><ref id="bib0685"><label>49</label><element-citation publication-type="journal" id="sbref0685"><person-group person-group-type="author"><name><surname>Salmi</surname><given-names>A.</given-names></name><name><surname>Ziola</surname><given-names>B.</given-names></name><name><surname>Hovi</surname><given-names>T.</given-names></name><name><surname>Reunanen</surname><given-names>M.</given-names></name></person-group><article-title>Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients</article-title><source>Neurology</source><volume>32</volume><year>1982</year><fpage>292</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">6278362</pub-id></element-citation></ref><ref id="bib0690"><label>50</label><element-citation publication-type="journal" id="sbref0690"><person-group person-group-type="author"><name><surname>Cristallo</surname><given-names>A.</given-names></name><name><surname>Gambaro</surname><given-names>F.</given-names></name><name><surname>Biamonti</surname><given-names>G.</given-names></name><name><surname>Ferrante</surname><given-names>P.</given-names></name><name><surname>Battaglia</surname><given-names>M.</given-names></name><name><surname>Cereda</surname><given-names>P.M.</given-names></name></person-group><article-title>Human coronavirus polyadenylated RNA sequences in cerebrospinal fluid from multiple sclerosis patients</article-title><source>Microbiologica</source><volume>2</volume><year>1997</year><fpage>105</fpage><lpage>114</lpage></element-citation></ref><ref id="bib0695"><label>51</label><element-citation publication-type="journal" id="sbref0695"><person-group person-group-type="author"><name><surname>Bonavia</surname><given-names>A.</given-names></name><name><surname>Arbour</surname><given-names>N.</given-names></name><name><surname>Yong</surname><given-names>V.W.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43</article-title><source>J Virol</source><volume>71</volume><year>1997</year><fpage>800</fpage><lpage>806</lpage><pub-id pub-id-type="pmid">8985420</pub-id></element-citation></ref><ref id="bib0700"><label>52</label><element-citation publication-type="journal" id="sbref0700"><person-group person-group-type="author"><name><surname>Arbour</surname><given-names>N.</given-names></name><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>G.</given-names></name><name><surname>Lachance</surname><given-names>C.</given-names></name><name><surname>Tardieu</surname><given-names>M.</given-names></name><name><surname>Cashman</surname><given-names>N.R.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Acute and persistent infection of human neural cell lines by human coronavirus OC43</article-title><source>J Virol</source><volume>73</volume><year>1999</year><fpage>3338</fpage><lpage>3350</lpage><pub-id pub-id-type="pmid">10074188</pub-id></element-citation></ref><ref id="bib0705"><label>53</label><element-citation publication-type="journal" id="sbref0705"><person-group person-group-type="author"><name><surname>Arbour</surname><given-names>N.</given-names></name><name><surname>&#x000c9;kand&#x000e9;</surname><given-names>S.</given-names></name><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>G.</given-names></name><name><surname>Lachance</surname><given-names>C.</given-names></name><name><surname>Chagnon</surname><given-names>F.</given-names></name><name><surname>Tardieu</surname><given-names>M.</given-names></name></person-group><article-title>Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E</article-title><source>J Virol</source><volume>73</volume><year>1999</year><fpage>3326</fpage><lpage>3337</lpage><pub-id pub-id-type="pmid">10074187</pub-id></element-citation></ref><ref id="bib0710"><label>54</label><element-citation publication-type="journal" id="sbref0710"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>O.</given-names></name><name><surname>Lygner</surname><given-names>P.E.</given-names></name><name><surname>Bergstrom</surname><given-names>T.</given-names></name><name><surname>Andersson</surname><given-names>M.</given-names></name><name><surname>Vahlne</surname><given-names>A.</given-names></name></person-group><article-title>Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study</article-title><source>J Neurol</source><volume>240</volume><year>1993</year><fpage>417</fpage><lpage>422</lpage><pub-id pub-id-type="pmid">8410082</pub-id></element-citation></ref><ref id="bib0715"><label>55</label><element-citation publication-type="journal" id="sbref0715"><person-group person-group-type="author"><name><surname>Sibley</surname><given-names>W.A.</given-names></name><name><surname>Bamford</surname><given-names>C.R.</given-names></name><name><surname>Clark</surname><given-names>K.</given-names></name></person-group><article-title>Clinical viral infections and multiple sclerosis</article-title><source>Lancet</source><volume>1</volume><year>1985</year><fpage>1313</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">2860501</pub-id></element-citation></ref><ref id="bib0720"><label>56</label><element-citation publication-type="journal" id="sbref0720"><person-group person-group-type="author"><name><surname>Barthold</surname><given-names>S.W.</given-names></name><name><surname>Smith</surname><given-names>A.L.</given-names></name></person-group><article-title>Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice</article-title><source>Arch Virol</source><volume>122</volume><year>1992</year><fpage>35</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">1309644</pub-id></element-citation></ref><ref id="bib0725"><label>57</label><element-citation publication-type="journal" id="sbref0725"><person-group person-group-type="author"><name><surname>Buchmeier</surname><given-names>M.J.</given-names></name><name><surname>Dalziel</surname><given-names>R.G.</given-names></name><name><surname>Koolen</surname><given-names>M.J.</given-names></name><name><surname>Lampert</surname><given-names>P.W.</given-names></name></person-group><article-title>Molecular determinants of CNS virulence of MHV-4</article-title><source>Adv Exp Med Biol</source><volume>218</volume><year>1987</year><fpage>287</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1007/978-1-4684-1280-2_38</pub-id><pub-id pub-id-type="pmid">2829542</pub-id></element-citation></ref><ref id="bib0730"><label>58</label><element-citation publication-type="journal" id="sbref0730"><person-group person-group-type="author"><name><surname>Hosking</surname><given-names>M.P.</given-names></name><name><surname>Lane</surname><given-names>T.E.</given-names></name></person-group><article-title>The pathogenesis of murine coronavirus infection of the central nervous system</article-title><source>Crit Rev Immunol</source><volume>30</volume><year>2010</year><fpage>119</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1615/CritRevImmunol.v30.i2.20</pub-id><pub-id pub-id-type="pmid">20370625</pub-id></element-citation></ref><ref id="bib0735"><label>59</label><element-citation publication-type="journal" id="sbref0735"><person-group person-group-type="author"><name><surname>Lavi</surname><given-names>E.</given-names></name><name><surname>Fishman</surname><given-names>P.S.</given-names></name><name><surname>Highkin</surname><given-names>M.K.</given-names></name><name><surname>Weiss</surname><given-names>S.R.</given-names></name></person-group><article-title>Limbic encephalitis after inhalation of a murine coronavirus</article-title><source>Lab Investig</source><volume>58</volume><year>1988</year><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">2826881</pub-id></element-citation></ref><ref id="bib0740"><label>60</label><element-citation publication-type="journal" id="sbref0740"><person-group person-group-type="author"><name><surname>Cabirac</surname><given-names>G.F.</given-names></name><name><surname>Soike</surname><given-names>K.F.</given-names></name><name><surname>Zhang</surname><given-names>J.Y.</given-names></name><name><surname>Hoel</surname><given-names>K.</given-names></name><name><surname>Butunoi</surname><given-names>C.</given-names></name><name><surname>Cai</surname><given-names>G.Y.</given-names></name></person-group><article-title>Entry of coronavirus into primate CNS following peripheral infection</article-title><source>Microb Pathog</source><volume>16</volume><year>1994</year><fpage>349</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">7815918</pub-id></element-citation></ref><ref id="bib0745"><label>61</label><element-citation publication-type="journal" id="sbref0745"><person-group person-group-type="author"><name><surname>Bleau</surname><given-names>C.</given-names></name><name><surname>Filliol</surname><given-names>A.</given-names></name><name><surname>Samson</surname><given-names>M.</given-names></name><name><surname>Lamontagne</surname><given-names>L.</given-names></name></person-group><article-title>Brain invasion by mouse hepatitis virus depends on impairment of tight junctions and beta interferon production in brain microvascular endothelial cells</article-title><source>J Virol</source><volume>89</volume><year>2015</year><fpage>9896</fpage><lpage>9908</lpage><pub-id pub-id-type="other">10.1128/JVI. 01501-15</pub-id><pub-id pub-id-type="pmid">26202229</pub-id></element-citation></ref><ref id="bib0750"><label>62</label><element-citation publication-type="journal" id="sbref0750"><person-group person-group-type="author"><name><surname>Savarin</surname><given-names>C.</given-names></name><name><surname>Bergmann</surname><given-names>C.C.</given-names></name></person-group><article-title>Fine tuning the cytokine storm by IFN and IL-10 following neurotropic coronavirus encephalomyelitis</article-title><source>Front Immunol</source><volume>9</volume><year>2018</year><fpage>3022</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.03022</pub-id><pub-id pub-id-type="pmid">30619363</pub-id></element-citation></ref><ref id="bib0755"><label>63</label><element-citation publication-type="journal" id="sbref0755"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>D.</given-names></name><name><surname>Addya</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>R.S.</given-names></name><name><surname>Kenyon</surname><given-names>L.C.</given-names></name><name><surname>Choe</surname><given-names>A.</given-names></name><name><surname>Cohrs</surname><given-names>R.J.</given-names></name></person-group><article-title>Mouse hepatitis virus infection upregulates genes involved in innate immune responses</article-title><source>PLoS One</source><volume>9</volume><year>2014</year><fpage>e111351</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0111351</pub-id><pub-id pub-id-type="pmid">25360880</pub-id></element-citation></ref><ref id="bib0760"><label>64</label><element-citation publication-type="journal" id="sbref0760"><person-group person-group-type="author"><name><surname>Ceccarelli</surname><given-names>M.</given-names></name><name><surname>Berretta</surname><given-names>M.</given-names></name><name><surname>Venanzi Rullo</surname><given-names>E.</given-names></name><name><surname>Nunnari</surname><given-names>G.</given-names></name><name><surname>Cacopardo</surname><given-names>B.</given-names></name></person-group><article-title>Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2 would a rose by another name smell as sweet?</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>24</volume><year>2020</year><fpage>2781</fpage><lpage>2783</lpage><pub-id pub-id-type="doi">10.26355/eurrev_202003_20551</pub-id><pub-id pub-id-type="pmid">32196628</pub-id></element-citation></ref><ref id="bib0765"><label>65</label><element-citation publication-type="journal" id="sbref0765"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Guan</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Tong</surname><given-names>Y.</given-names></name></person-group><article-title>Early transmission dynamics in wuhan china, of novel coronavirus-infected pneumonia</article-title><source>Engl J Med</source><year>2020</year><pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id></element-citation></ref><ref id="bib0770"><label>66</label><element-citation publication-type="journal" id="sbref0770"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J.</given-names></name></person-group><article-title>Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses</article-title><source>Microbes Infect</source><year>2020</year><pub-id pub-id-type="doi">10.1016/j.micinf.2020.01.004</pub-id></element-citation></ref><ref id="bib0775"><label>67</label><element-citation publication-type="journal" id="sbref0775"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>C.C.</given-names></name><name><surname>Shih</surname><given-names>T.P.</given-names></name><name><surname>Ko</surname><given-names>W.C.</given-names></name><name><surname>Tang</surname><given-names>H.J.</given-names></name><name><surname>Hsueh</surname><given-names>P.R.</given-names></name></person-group><article-title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges</article-title><source>Int J Antimicrob Agents</source><year>2020</year><fpage>105924</fpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105924</pub-id><pub-id pub-id-type="pmid">32081636</pub-id></element-citation></ref><ref id="bib0780"><label>68</label><element-citation publication-type="journal" id="sbref0780"><person-group person-group-type="author"><name><surname>Perrella</surname><given-names>A.</given-names></name><name><surname>Carannante</surname><given-names>N.</given-names></name><name><surname>Berretta</surname><given-names>M.</given-names></name><name><surname>Rinaldi</surname><given-names>M.</given-names></name><name><surname>Maturo</surname><given-names>N.</given-names></name><name><surname>Rinaldi</surname><given-names>L.</given-names></name></person-group><article-title>Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches?</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>24</volume><year>2020</year><fpage>2162</fpage><lpage>2164</lpage><pub-id pub-id-type="doi">10.26355/eurrev_202002_20396</pub-id><pub-id pub-id-type="pmid">32141586</pub-id></element-citation></ref><ref id="bib0785"><label>69</label><element-citation publication-type="journal" id="sbref0785"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Du</surname><given-names>R.H.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Zheng</surname><given-names>X.S.</given-names></name><name><surname>Yang</surname><given-names>X.L.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name></person-group><article-title>Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes</article-title><source>Emerg Microbes Infect</source><volume>9</volume><year>2020</year><fpage>386</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">32065057</pub-id></element-citation></ref><ref id="bib0790"><label>70</label><element-citation publication-type="journal" id="sbref0790"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Zhou</surname><given-names>M.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Qu</surname><given-names>J.</given-names></name><name><surname>Gong</surname><given-names>F.</given-names></name><name><surname>Han</surname><given-names>Y.</given-names></name></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</article-title><source>Lancet</source><volume>395</volume><year>2020</year><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id><pub-id pub-id-type="pmid">32007143</pub-id></element-citation></ref><ref id="bib0795"><label>71</label><element-citation publication-type="journal" id="sbref0795"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Ren</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title><source>Lancet</source><year>2020</year><fpage>395497</fpage><lpage>395506</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id></element-citation></ref><ref id="bib0800"><label>72</label><element-citation publication-type="journal" id="sbref0800"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name><name><surname>Hu</surname><given-names>C.</given-names></name><name><surname>Zhu</surname><given-names>F.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name></person-group><article-title>Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China</article-title><source>JAMA</source><year>2020</year><pub-id pub-id-type="doi">10.1001/jama.2020.1585</pub-id></element-citation></ref><ref id="bib0805"><label>73</label><element-citation publication-type="journal" id="sbref0805"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X.W.</given-names></name><name><surname>Wu</surname><given-names>X.X.</given-names></name><name><surname>Jiang</surname><given-names>X.G.</given-names></name><name><surname>Xu</surname><given-names>K.J.</given-names></name><name><surname>Ying</surname><given-names>L.J.</given-names></name><name><surname>Ma</surname><given-names>C.L.</given-names></name></person-group><article-title>Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series</article-title><source>BMJ</source><volume>368</volume><year>2020</year><fpage>606</fpage><pub-id pub-id-type="doi">10.1136/bmj.m606</pub-id></element-citation></ref><ref id="bib0810"><label>74</label><element-citation publication-type="journal" id="sbref0810"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>K.</given-names></name><name><surname>Fang</surname><given-names>Y.Y.</given-names></name><name><surname>Deng</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>M.F.</given-names></name><name><surname>Ma</surname><given-names>J.P.</given-names></name></person-group><article-title>Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province</article-title><source>Chin Med J (Engl)</source><year>2020</year><pub-id pub-id-type="doi">10.1097/CM9.0000000000000744</pub-id></element-citation></ref><ref id="bib0815"><label>75</label><element-citation publication-type="journal" id="sbref0815"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Shu</surname><given-names>H.</given-names></name><name><surname>Xia</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name></person-group><article-title>Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study</article-title><source>Lancet Respir Med</source><year>2020</year><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30079-5</pub-id></element-citation></ref><ref id="bib0820"><label>76</label><mixed-citation publication-type="other" id="oref0380">Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. BMJ. doi:10.1101/2020.02.22.20026500.</mixed-citation></ref><ref id="bib0825"><label>77</label><element-citation publication-type="journal" id="sbref0825"><person-group person-group-type="author"><name><surname>Filatov</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Hindi</surname><given-names>F.</given-names></name><name><surname>Espinosa</surname><given-names>P.</given-names></name></person-group><article-title>Neurological complications of coronavirus disease (COVID-19): encephalopathy</article-title><source>Cureus</source><volume>12</volume><year>2020</year><fpage>e7352</fpage><pub-id pub-id-type="doi">10.7759/cureus.7352</pub-id><pub-id pub-id-type="pmid">32328364</pub-id></element-citation></ref><ref id="bib0830"><label>78</label><element-citation publication-type="journal" id="sbref0830"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.C.</given-names></name><name><surname>Bai</surname><given-names>W.Z.</given-names></name><name><surname>Hashikawa</surname><given-names>T.</given-names></name></person-group><article-title>The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients</article-title><source>J Med Virol</source><year>2020</year><pub-id pub-id-type="doi">10.1002/jmv.25728</pub-id></element-citation></ref><ref id="bib0835"><label>79</label><element-citation publication-type="journal" id="sbref0835"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>A.R.</given-names></name><name><surname>Perlman</surname><given-names>S.</given-names></name></person-group><article-title>Coronaviruses: an overview of their replication and pathogenesis</article-title><source>Methods Mol Biol</source><volume>1282</volume><year>2015</year><fpage>1</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">25720466</pub-id></element-citation></ref><ref id="bib0840"><label>80</label><element-citation publication-type="journal" id="sbref0840"><person-group person-group-type="author"><name><surname>Desforges</surname><given-names>M.</given-names></name><name><surname>Le Coupanec</surname><given-names>A.</given-names></name><name><surname>Brison</surname><given-names>E.</given-names></name><name><surname>Meessen-Pinard</surname><given-names>M.</given-names></name><name><surname>Talbot</surname><given-names>P.J.</given-names></name></person-group><article-title>Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans</article-title><source>Adv Exp Med Biol</source><volume>807</volume><year>2014</year><fpage>75</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1007/978-81-322-1777-0_6</pub-id><pub-id pub-id-type="pmid">24619619</pub-id></element-citation></ref><ref id="bib0845"><label>81</label><element-citation publication-type="journal" id="sbref0845"><person-group person-group-type="author"><name><surname>Narayanan</surname><given-names>K.</given-names></name><name><surname>Ramirez</surname><given-names>S.I.</given-names></name><name><surname>Lokugamage</surname><given-names>K.G.</given-names></name><name><surname>Makino</surname><given-names>S.</given-names></name></person-group><article-title>Coronavirus nonstructural protein 1: common and distinct functions in the regulation of host and viral gene expression</article-title><source>Virus Res</source><volume>202</volume><year>2015</year><fpage>89</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">25432065</pub-id></element-citation></ref><ref id="bib0850"><label>82</label><element-citation publication-type="journal" id="sbref0850"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Kok</surname><given-names>K.H.</given-names></name><name><surname>Zhu</surname><given-names>Z.</given-names></name><name><surname>Chu</surname><given-names>H.</given-names></name><name><surname>To</surname><given-names>K.K.</given-names></name><name><surname>Yuan</surname><given-names>S.</given-names></name></person-group><article-title>Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan</article-title><source>Emerg Microbes Infect</source><volume>9</volume><year>2020</year><fpage>221</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1080/22221751.2020.1719902</pub-id><pub-id pub-id-type="pmid">31987001</pub-id></element-citation></ref><ref id="bib0855"><label>83</label><element-citation publication-type="journal" id="sbref0855"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>J.F.</given-names></name><name><surname>Zhang</surname><given-names>A.J.</given-names></name><name><surname>Yuan</surname><given-names>S.</given-names></name><name><surname>Poon</surname><given-names>V.K.</given-names></name><name><surname>Chan</surname><given-names>C.C.</given-names></name><name><surname>Lee</surname><given-names>A.C.</given-names></name></person-group><article-title>Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility</article-title><source>Clin Infect Dis</source><volume>325</volume><year>2020</year><pub-id pub-id-type="doi">10.1093/cid/ciaa325</pub-id></element-citation></ref><ref id="bib0860"><label>84</label><element-citation publication-type="journal" id="sbref0860"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Sui</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>I.C.</given-names></name><name><surname>Kuhn</surname><given-names>J.H.</given-names></name><name><surname>Radoshitzky</surname><given-names>S.R.</given-names></name><name><surname>Marasco</surname><given-names>W.A.</given-names></name></person-group><article-title>The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2</article-title><source>Virology</source><volume>367</volume><year>2007</year><fpage>367</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2007.04.035</pub-id><pub-id pub-id-type="pmid">17631932</pub-id></element-citation></ref><ref id="bib0865"><label>85</label><element-citation publication-type="journal" id="sbref0865"><person-group person-group-type="author"><name><surname>Baig</surname><given-names>A.M.</given-names></name><name><surname>Khaleeq</surname><given-names>A.</given-names></name><name><surname>Ali</surname><given-names>U.</given-names></name><name><surname>Syeda</surname><given-names>H.</given-names></name></person-group><article-title>Evidence of the COVID-19 virus targeting the CNS: tissue distribution host-virus interaction, and proposed neurotropic mechanisms</article-title><source>CS Chem Neurosci</source><year>2020</year><pub-id pub-id-type="doi">10.1021/acschemneuro.0c00122</pub-id></element-citation></ref><ref id="bib0870"><label>86</label><element-citation publication-type="journal" id="sbref0870"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>H.</given-names></name><name><surname>Geier</surname><given-names>M.</given-names></name><name><surname>Marzi</surname><given-names>A.</given-names></name><name><surname>Krumbiegel</surname><given-names>M.</given-names></name><name><surname>Peipp</surname><given-names>M.</given-names></name><name><surname>Fey</surname><given-names>G.H.</given-names></name></person-group><article-title>Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor</article-title><source>Biochem Biophys Res Commun</source><volume>319</volume><year>2004</year><fpage>1216</fpage><lpage>1221</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.05.114</pub-id><pub-id pub-id-type="pmid">15194496</pub-id></element-citation></ref><ref id="bib0875"><label>87</label><element-citation publication-type="journal" id="sbref0875"><person-group person-group-type="author"><name><surname>Joob</surname><given-names>B.</given-names></name><name><surname>Wiwanitkit</surname><given-names>V.</given-names></name></person-group><article-title>Neurologic syndrome due to MERS: is there a possibility that the virus can cross the blood-brain barrier to cause a neurological problem?</article-title><source>Ann Trop Med Public Health</source><volume>8</volume><year>2015</year><fpage>231</fpage><pub-id pub-id-type="doi">10.4103/1755-6783.162654</pub-id></element-citation></ref><ref id="bib0880"><label>88</label><element-citation publication-type="journal" id="sbref0880"><person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>O.</given-names></name><name><surname>Coulter-Mackie</surname><given-names>M.B.</given-names></name><name><surname>Puchalski</surname><given-names>S.</given-names></name><name><surname>Dales</surname><given-names>S.</given-names></name></person-group><article-title>In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases</article-title><source>Virology</source><volume>137</volume><year>1984</year><fpage>347</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">6091333</pub-id></element-citation></ref></ref-list><fn-group><fn id="d32e719"><label>&#x02606;</label><p id="npar0005">Please cite this article as: Mat&#x000ed;as-Guiu J, Gomez-Pinedo U, Montero-Escribano P, Gomez-Iglesias P, Porta-Etessam J, Matias-Guiu JA. &#x000bf;Es esperable que haya cuadros neurol&#x000f3;gicos por la pandemia por SARS-CoV-2? Neurolog&#x000ed;a. 2020;35:170&#x02013;175.</p></fn></fn-group></back></article>